Copy to clipboard 
Greenlight Guru received an investment from JMI Equity (JMI), a growth equity firm focused on investing in leading software companies.
Over the past year, medical device companies were forced to adapt to many changes, including a tsunami of global regulatory updates, an increased need for cloud-based software due to remote work, and a rise in supply chain management issues. Greenlight Guru’s industry-specific software has proven critical in helping medical device companies thrive in spite of challenging, unpredictable times. Its all-in-one medical device success platform enables device companies across the globe to bring products to market faster by streamlining the registration, approval, and certification processes while providing a single source of truth for quality, product development, and regulatory management.
This investment from JMI will enable Greenlight Guru to accelerate product development efforts, rapidly expand its product capabilities across the patient-centric value chain, and support significant global growth. After releasing Halo, the world’s first and only artificial intelligence and ML-powered recommendation engine for medical device quality, the Greenlight Guru team is excited to help device makers continue to reimagine the way quality works, being proactive rather than reactive, and deliver on the promises of Smart Quality.
“We listened to the needs of the medical device industry and chose JMI Equity as a strategic partner because they are experts at achieving growth by putting the customer first,” said David DeRam, CEO of Greenlight Guru. “We’ve been extremely deliberate when taking on investment because we wanted to ensure we found the right partner for us and our customers. This partnership will allow us to accelerate the value we provide to our customers as we remain committed to helping medical device companies get their life-changing products to patients and achieve our mission of improving the quality of life.”
Greenlight Guru’s medical device success platform helps companies bring safer products to market faster, simplifies FDA and ISO regulatory compliance, and connects the management of quality, product development, and regulatory processes.
